Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury

Kaori Tenkumo, Kazuyuki Hirooka, Shamshad J. Sherajee, Takehiro Nakamura, Toshifumi Itano, Eri Nitta, Tomoyoshi Fujita, Akira Nishiyama, Fumio Shiraga

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The purpose of this study was to investigate the effect of the renin inhibitor, aliskiren, on retinal ischemia-reperfusion injury. Retinal ischemia was induced by increasing intraocular pressure to 130mmHg. At 7 days after ischemia, retinal damage was evaluated by measuring the retinal thickness and the number of retinal ganglion cells. Western blot was used to measure changes in the (pro)renin receptor expression. Retinal mRNA expressions of prorenin, angiotensinogen and angiotensin II type 1 receptor (AT1-R) were measured by real-time polymerase chain reaction. Rats were treated with the renin inhibitor, aliskiren. Although the number of retinal ganglion cells and the inner retinal thickness were significantly decreased at 7 days after ischemia, treatment with aliskiren significantly inhibited retinal ischemic injury. Administration of aliskiren increased mRNA expression of prorenin in the retina at 3h after the reperfusion. The expression of the (pro)renin receptor was not changed after ischemia-reperfusion injury with or without aliskiren. Although there was an increase in the retinal expression of AT1-R at 3h after the reperfusion, aliskiren administration suppressed this expression. A renin inhibitor attenuated subsequent ischemic damage in the rat retina via the inhibition of the prorenin-induced angiotensin generation.

Original languageEnglish
Pages (from-to)110-118
Number of pages9
JournalExperimental Eye Research
Volume122
DOIs
Publication statusPublished - 2014

Fingerprint

Reperfusion Injury
Renin
Angiotensin Type 1 Receptor
Ischemia
Retinal Ganglion Cells
Reperfusion
Retina
Angiotensinogen
Messenger RNA
aliskiren
Angiotensins
Intraocular Pressure
Real-Time Polymerase Chain Reaction
Western Blotting
Wounds and Injuries

Keywords

  • (pro)renin
  • Aliskiren
  • Angiotensin II type 1 receptor (AT1-R)
  • Angiotensinogen
  • Renin
  • Renin-angiotensin-aldosterone-system
  • Retinal ischemia

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury. / Tenkumo, Kaori; Hirooka, Kazuyuki; Sherajee, Shamshad J.; Nakamura, Takehiro; Itano, Toshifumi; Nitta, Eri; Fujita, Tomoyoshi; Nishiyama, Akira; Shiraga, Fumio.

In: Experimental Eye Research, Vol. 122, 2014, p. 110-118.

Research output: Contribution to journalArticle

Tenkumo, K, Hirooka, K, Sherajee, SJ, Nakamura, T, Itano, T, Nitta, E, Fujita, T, Nishiyama, A & Shiraga, F 2014, 'Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury', Experimental Eye Research, vol. 122, pp. 110-118. https://doi.org/10.1016/j.exer.2014.03.011
Tenkumo, Kaori ; Hirooka, Kazuyuki ; Sherajee, Shamshad J. ; Nakamura, Takehiro ; Itano, Toshifumi ; Nitta, Eri ; Fujita, Tomoyoshi ; Nishiyama, Akira ; Shiraga, Fumio. / Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury. In: Experimental Eye Research. 2014 ; Vol. 122. pp. 110-118.
@article{9c5998d6ce6143d196834599d6bdc6d1,
title = "Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury",
abstract = "The purpose of this study was to investigate the effect of the renin inhibitor, aliskiren, on retinal ischemia-reperfusion injury. Retinal ischemia was induced by increasing intraocular pressure to 130mmHg. At 7 days after ischemia, retinal damage was evaluated by measuring the retinal thickness and the number of retinal ganglion cells. Western blot was used to measure changes in the (pro)renin receptor expression. Retinal mRNA expressions of prorenin, angiotensinogen and angiotensin II type 1 receptor (AT1-R) were measured by real-time polymerase chain reaction. Rats were treated with the renin inhibitor, aliskiren. Although the number of retinal ganglion cells and the inner retinal thickness were significantly decreased at 7 days after ischemia, treatment with aliskiren significantly inhibited retinal ischemic injury. Administration of aliskiren increased mRNA expression of prorenin in the retina at 3h after the reperfusion. The expression of the (pro)renin receptor was not changed after ischemia-reperfusion injury with or without aliskiren. Although there was an increase in the retinal expression of AT1-R at 3h after the reperfusion, aliskiren administration suppressed this expression. A renin inhibitor attenuated subsequent ischemic damage in the rat retina via the inhibition of the prorenin-induced angiotensin generation.",
keywords = "(pro)renin, Aliskiren, Angiotensin II type 1 receptor (AT1-R), Angiotensinogen, Renin, Renin-angiotensin-aldosterone-system, Retinal ischemia",
author = "Kaori Tenkumo and Kazuyuki Hirooka and Sherajee, {Shamshad J.} and Takehiro Nakamura and Toshifumi Itano and Eri Nitta and Tomoyoshi Fujita and Akira Nishiyama and Fumio Shiraga",
year = "2014",
doi = "10.1016/j.exer.2014.03.011",
language = "English",
volume = "122",
pages = "110--118",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury

AU - Tenkumo, Kaori

AU - Hirooka, Kazuyuki

AU - Sherajee, Shamshad J.

AU - Nakamura, Takehiro

AU - Itano, Toshifumi

AU - Nitta, Eri

AU - Fujita, Tomoyoshi

AU - Nishiyama, Akira

AU - Shiraga, Fumio

PY - 2014

Y1 - 2014

N2 - The purpose of this study was to investigate the effect of the renin inhibitor, aliskiren, on retinal ischemia-reperfusion injury. Retinal ischemia was induced by increasing intraocular pressure to 130mmHg. At 7 days after ischemia, retinal damage was evaluated by measuring the retinal thickness and the number of retinal ganglion cells. Western blot was used to measure changes in the (pro)renin receptor expression. Retinal mRNA expressions of prorenin, angiotensinogen and angiotensin II type 1 receptor (AT1-R) were measured by real-time polymerase chain reaction. Rats were treated with the renin inhibitor, aliskiren. Although the number of retinal ganglion cells and the inner retinal thickness were significantly decreased at 7 days after ischemia, treatment with aliskiren significantly inhibited retinal ischemic injury. Administration of aliskiren increased mRNA expression of prorenin in the retina at 3h after the reperfusion. The expression of the (pro)renin receptor was not changed after ischemia-reperfusion injury with or without aliskiren. Although there was an increase in the retinal expression of AT1-R at 3h after the reperfusion, aliskiren administration suppressed this expression. A renin inhibitor attenuated subsequent ischemic damage in the rat retina via the inhibition of the prorenin-induced angiotensin generation.

AB - The purpose of this study was to investigate the effect of the renin inhibitor, aliskiren, on retinal ischemia-reperfusion injury. Retinal ischemia was induced by increasing intraocular pressure to 130mmHg. At 7 days after ischemia, retinal damage was evaluated by measuring the retinal thickness and the number of retinal ganglion cells. Western blot was used to measure changes in the (pro)renin receptor expression. Retinal mRNA expressions of prorenin, angiotensinogen and angiotensin II type 1 receptor (AT1-R) were measured by real-time polymerase chain reaction. Rats were treated with the renin inhibitor, aliskiren. Although the number of retinal ganglion cells and the inner retinal thickness were significantly decreased at 7 days after ischemia, treatment with aliskiren significantly inhibited retinal ischemic injury. Administration of aliskiren increased mRNA expression of prorenin in the retina at 3h after the reperfusion. The expression of the (pro)renin receptor was not changed after ischemia-reperfusion injury with or without aliskiren. Although there was an increase in the retinal expression of AT1-R at 3h after the reperfusion, aliskiren administration suppressed this expression. A renin inhibitor attenuated subsequent ischemic damage in the rat retina via the inhibition of the prorenin-induced angiotensin generation.

KW - (pro)renin

KW - Aliskiren

KW - Angiotensin II type 1 receptor (AT1-R)

KW - Angiotensinogen

KW - Renin

KW - Renin-angiotensin-aldosterone-system

KW - Retinal ischemia

UR - http://www.scopus.com/inward/record.url?scp=84898681109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898681109&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2014.03.011

DO - 10.1016/j.exer.2014.03.011

M3 - Article

C2 - 24709336

AN - SCOPUS:84898681109

VL - 122

SP - 110

EP - 118

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

ER -